In October 2015, the Commission for the Protection against Sanitary Risk (COFEPRIS) gave Mexico the registry of the first recombinant vaccine against seasonal influenza in the world and designed to begin marketing in the first quarter of 2016.
In October 2015, the Commission for the Protection against Sanitary Risk (COFEPRIS) gave Mexico the registry of the first recombinant vaccine against seasonal influenza in the world and designed to begin marketing in the first quarter of 2016.
Flu immunisations with four times the strength of standard flu shots significantly reduces the risk hospitalisation of the elderly during the influenza season, new research has found.